BCYC position history
The shares of Bicycle Therapeutics (BCYC) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 53,200 shares, $2.3M, 0.61% of portfolio, New
- 2022 Q2: 131,200 shares, $2.2M, 0.60% of portfolio, Add +146.6%
- 2022 Q3: 122,200 shares, $2.8M, 0.76% of portfolio, Reduce −6.9%
- 2022 Q4: 122,200 shares, $3.6M, 1.0% of portfolio
- 2023 Q1: 122,200 shares, $2.6M, 0.78% of portfolio
- 2023 Q2: 122,200 shares, $3.1M, 0.85% of portfolio
- 2023 Q3: 122,200 shares, $2.5M, 0.76% of portfolio
- 2023 Q4: 122,200 shares, $2.2M, 0.53% of portfolio
- 2024 Q1: 122,200 shares, $3M, 0.69% of portfolio
- 2024 Q2: 122,200 shares, $2.5M, 0.59% of portfolio
- 2024 Q3: 122,200 shares, $2.8M, 0.65% of portfolio
- 2024 Q4: 120,799 shares, $1.7M, 0.43% of portfolio, Reduce −1.1%
- 2025 Q1: 80,799 shares, $686K, 0.19% of portfolio, Reduce −33.1%
- 2025 Q2: 64,492 shares, $448K, 0.12% of portfolio, Reduce −20.2%
- 2025 Q3: 64,492 shares, $499K, 0.12% of portfolio
- 2025 Q4: 64,492 shares, $457K, 0.11% of portfolio
- 2026 Q1: 64,492 shares, $299K, 0.07% of portfolio
- 2026 Q2: 64,492 shares, $273K, 0.05% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|